Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychiatric drugs
Biotech
Big Pharma-backed MapLight plots IPO
Should the listing go through, MapLight would become just the second biotech to go public since February.
Darren Incorvaia
Sep 22, 2025 1:57pm
AbbVie inks $1.2B deal to buy Gilgamesh's psychedelic program
Aug 25, 2025 9:42am
Arialys presents promising data for IgG1 antibody treatment
Jun 20, 2025 5:02am
AbbVie makes Richter richer, paying $25M to form discovery pact
Oct 25, 2024 7:55am
AbbVie pens $2B-plus neuro pact with Gilgamesh
May 13, 2024 5:57pm
Headlands acquires Pharmasite to expand mental health trials
Feb 29, 2024 4:20pm
